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Prasenjit Mukherjee1, Someswar Datta2, Soumya Sarkar3, Jayanta Mukherjee4, Shalini Nath5, 
Vamsi K. Balla2 & Chitra Mandal5
Effects of strontium and lithium ion doping on the biological properties of bioactive glass (BAG) porous 
scaffolds have been checked in vitro and in vivo. BAG scaffolds were prepared by conventional glass 
melting route and subsequently, scaffolds were produced by evaporation of fugitive pore formers. 
After thorough physico-chemical and in vitro cell characterization, scaffolds were used for pre-clinical 
study. Soft and hard tissue formation in a rabbit femoral defect model after 2 and 4 months, were 
assessed using different tools. Histological observations showed excellent osseous tissue formation in 
Sr and Li + Sr scaffolds and moderate bone regeneration in Li scaffolds. Fluorochrome labeling studies 
showed wide regions of new bone formation in Sr and Li + Sr doped samples as compared to Li doped 
samples. SEM revealed abundant collagenous network and minimal or no interfacial gap between bone 
and implant in Sr and Li + Sr doped samples compared to Li doped samples. Micro CT of Li + Sr samples 
showed highest degree of peripheral cancellous tissue formation on periphery and cortical tissues inside 
implanted samples and vascularity among four compositions. Our findings suggest that addition of Sr 
and/or Li alters physico-chemical properties of BAG and promotes early stage in vivo osseointegration 
and bone remodeling that may offer new insight in bone tissue engineering.
The management of bone defects still remains a challenge for orthopedic surgeons. It has been reported that 
occurrence of impaired fracture healing of bone defects is nearly 5–10%1. In United States alone, 1.3 million peo-
ple undergo bone graft surgeries each year for skeletal defects resulting from either accidents or disease2. Bone 
grafting, either from autografts or allografts is a well-known surgical procedure although has associated draw-
backs of additional surgery, limited availability, potential risks of disease transmission, immunogenic response 
and long-term complications3. To overcome these limitations, the development as well as the availability of new 
orthobiologic materials to aid in the management of bony defects is rising.
On the other hand, tissue engineering mainly with engineered grafts is now-a-days a major thrust area toward 
repair and replacement of these diseased and damaged bone tissues. To achieve this goal, bioactive glasses and 
calcium phosphate have been investigated as bone repair scaffolds but having some limitations4,5. Mechanical and 
osteoinductive properties of scaffold materials can be improved via metallic ions substitution6. Among various ion 
substitutions, strontium (Sr2+), zinc (Zn2+), magnesium (Mg2+) and silicon (Si4+) have been widely studied7–13. 
Sr was the only one that was correlated with an increase in bone compression strength14. Stimulatory effect of 
Sr on osteoblasts and inhibitory effect on osteoclasts have been established15–18. Further, strontium ranelate has 
been proven to reduce the incidence of fractures in osteoporotic elderly patients19. Similarly, lithium (Li+) plays 
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a vital role in osteoblast proliferation and differentiation through stimulation of the Wnt signaling pathway20,21. 
An earlier study demonstrated increased in vitro proliferative activity only at low Li+ concentration (0.25 wt. %)22.
Bioactive glasses with interconnected porosity with large surface areas are also favorable for bone integration. 
These materials with such structures have also been found to support angiogenesis23,24, osteoproduction by stim-
ulating proliferation and differentiation of osteoprogenitor cells through direct genetic control25. Glass-ceramics 
and bioactive glasses with Sr2+ doping have been attempted recently26,27. Strontium-doped bioactive glasses have 
also been developed28.
Single and binary doping of Sr2+ and Li+ on in vivo bone regeneration of bioactive glasses scaffolds has not 
been reported yet. In the present study we have made an attempt to assess the beneficial effects of Sr2+ and Li+ 
doping on in vivo bone formation of an interconnected bioactive glass porous scaffold developed in the laboratory 
through rabbit bone defect model. Detailed phase, composition and microstructure analysis were performed 
prior using tools like X-ray diffraction (XRD), Fourier transformed infrared spectroscopy (FTIR), differential 
thermal analysis-thermo-gravimetric analysis (DTA-TGA), quantitative EDAX analysis and scanning electron 
microscopy (SEM) respectively. The scaffolds were also assessed for its bioactivity in contact with simulated body 
fluid (SBF) and in vitro cyto-toxicity by MTT assay using NIH3T3. The in vivo bone regeneration was analyzed 
using chronological radiography, fluorochrome labeling, SEM, histology and micro-computed tomography 
(μ -CT).
Materials and Methods
Bioactive glass scaffold preparation. Bioactive glass (with or without doping of Li or Sr) was prepared 
through conventional glass melting procedure using appropriate amounts of reagents like silica (SiO2), calcium 
carbonate (CaCO3), dry soda ash (Na2CO3), decahydrated borax (Na2B4O7.10H2O), TiO2, di-ammonium hydro-
gen ortho-phosphate, lithium and strontium carbonate (all inorganic chemicals including the ones referred later 
in the manuscript were analytical grade from M/s S.D. Fine-Chem Limited, India until specified seperately). 
Briefly, reagents were first mixed homogeneously, melted at 1450 °C in a Pt-crucible, homogeneity was main-
tained while melting and finally quenched in water to obtain the cullet. Dried cullets were further milled in a high 
energy ball mill for 3 h in aqueous medium. The final compostion of the as-prepared glass powders (obtained by 
ICP-AES chemical analysis) is given in Table 1. 0.25% Li2O and 1% SrO (by weight) doping was used strategically 
for the base glass composition and nomenclatures like BAG, L-BAG, S-BAG and LS-BAG were given for bioactive 
glass without doping, Li-, Sr- and binary Li + Sr substitution respectively and used throughout the manuscript.
To fabricate porous scaffolds, milled as-prepared respective glass powders were first mixed with an equal 
quantity of porogen (scintillation grade naphthalene). The resultant mix was compacted at 150 MPa in a 
cold-isostatic press (EPSI, Belgium); cut into 8 mm diameter specimens using a low speed diamond saw (Isomet, 
Buehler, USA). Subsequently, naphthalene was driven off very slowly (from r.t. to 80 °C) with pre-determined 
rate of schedule, followed by heat treatment at 675 °C except for LS-BAG (650 °C) on a Pt-plate for 6 min. These 
temperatures were selected after careful assessment of glass-transition temperatures (Tg) mentioned later. The 
samples were finally stored in a vacuum desiccator until further use.
Bioactive glass powders and scaffold characterization. Both as-prepared and heat treated powders 
were analyzed for phase by XRD at a diffraction angle of 10–80°2θ [X’Pert Pro, Phillips Analytical, Netherlands; 
Cu Kα1 radiation; scan speed 2° min−1. FTIR transmittance spectra was recorded at mid-IR range (4000–
400 cm−1) [Spectrum 100, PerkinElmer, USA; resolution: 2 cm−1; by KBr pellet method] to confirm the func-
tional groups present. On the other hand, DTA-TGA was conducted to determine the thermal profiles of the 
glass powders [STA 449C, Netzsch, Germany; rate of heating upto 1000 °C: 10 °C/min. with initial sample mass 
of 5 ± 0.5 mg]. Heat treatment temperatures of BAG, L-BAG, S-BAG and LS-BAG were selected by assessing the 
Tg by the same DTA-TGA analysis.
Further, porous scaffolds were first physically characterized for open or apparent porosity (A.P.) and bulk 
density (B.D.) by water displacement method (Archimedes’ principle), then by a table-top SEM (Phenom pro-X, 
Netherlands) for detailed microstructural characterization and assessment of pore size, shape and morphology 
with Au/Pd sputter coating on the samples prior. B.D. was calculated by [D/(W-S)] and A.P. by [(W-D)/(W-S)] x 
100%, where D, W and S are dry, soaked and suspended weight of the samples respectively while calculating by 
Constituent
Mean wt. %
BAG L-BAG S-BAG LS-BAG
SiO2 55.50 55.77 53.92 55.02
B2O3 1.38 1.76 2.33 1.00
CaO 23.60 23.95 23.00 23.36
Na2O 10.80 10.01 11.00 9.94
P2O5 5.74 5.85 5.59 5.59
TiO2 1.64 1.71 2.00 1.88
Li2O — 0.22 — 0.30
SrO2 — — 1.12 1.00
Table 1.  Chemical composition of the as-prepared powders by ICP-AES.
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the methods mentioned. Variations of pore sizes were calculated by processing several SEM images thus obtained 
and using free software available (Perfect Screen Ruler v. 2.0) subsequently.
SBF bioactivity study. Primary bioactivity study of the bare scaffolds was carried out in contact with SBF, 
before in vitro cell cytotoxicity and in vivo pre-clinical study just to check calcium and phosphate ion deposition 
ability of the samples. Supernatants were analyzed for Ca2+, HCO3−, and HPO4− ions. SBF was prepared as per 
Kokubo et al.29. All the samples were selected with surface area of sample and volume of SBF taken with ratio 
of 2 mm2/mL (e.g., 40 mm2/20 mL) and soaked for 7 and 14 days. Samples were kept statically at a temperature 
37.4 °C with pH 7.4 inside an incubator. After 7 and 14 days, ion concentrations were plotted and analyzed. One 
of respective samples (from BAG, L-BAG, S-BAG and LS-BAG) was seen for microstructure by FESEM (using 
Sigma, Carl Zeiss, Germany) after day 14. The samples were dried and carbon sputter coated prior observation.
In vitro cell cytotoxicity. Chemicals used: Iscove’s modified Dulbecco’s medium (IMDM), 
phosphate-buffered saline (PBS), formaldehyde, 3-(4,5 dimethyl thiazol-2yl)-2,5 diphenyltetrazolium bromide 
(MTT), osmium tetroxide, paraformaldehyde, dimethyl sulfoxide (DMSO) were from Sigma Aldrich, St. Louis 
USA; fetal bovine serum (FBS) and penicillin/streptomycin, trypsin-ethylenediaminetetra acetic acid (EDTA), 
L-glutamine were from Invitrogen, CA,USA.
Fibroblast (NIH3T3) cell line (NCCS, Pune, India) was cultured in IMDM supplemented with 10% FBS and 
1% penicillin-streptomycin (Complete Medium) in a humidified atmosphere of 5% CO2 at 37 °C. BAG, S-BAG, 
L-BAG, LS-BAG scaffolds were autoclaved and then rinsed with 70% alcohol for sterilization. NIH3T3 (2 × 103) 
cells were seeded on scaffolds which were previously placed in a 24 well plate. Cells were allowed to attach on the 
surface of scaffolds for 2 h. Subsequently another 1.0 mL of complete medium was added in each well and cultured 
on for 3 and 7 days. Culture medium was changed in every 2 days.
To test cytotoxicity of BAG, S-BAG, L-BAG, LS-BAG scaffolds on cells, MTT assay was carried out after 3 
and 7 days of culture. Cell without scaffold was used as control. MTT solution was prepared by dissolving MTT 
(5.0 mg) in DMSO (1.0 mL). MTT (100 μ L) solution was diluted with IMDM (900 μ L). After removing the pre-
vious medium diluted MTT solution was added in each well and incubated for 3 h. Purple coloured formazan 
crystal which are formed by the oxidation of tetrazolium salt by mitochondrial succinate dehydrogenase enzyme 
was dissolved in DMSO (500 μ L). The resulting solution (200 μ L) was placed into a 96 well plate and the optical 
density at 550 nm was measured using plate reader (Thermo Scientific). Each experiment was carried out in trip-
licate and the results were presented as means ± SD.
Cell morphology by SEM. NIH3T3 (2 × 103) cells were seeded on scaffolds and cultured for 7 days. 
Scaffolds containing cells were washed with PBS (0.1 M) and fixed with paraformaldehyde (2%) overnight at 4 °C. 
Subsequently, it was fixed with 2% osmium tetroxide (OsO4) for 2 h at 25 °C. The fixed samples were then dehy-
drated in an ethanol series 30%, 50%, 70%, 90% and 100% each for three times, followed by gold sputter coating 
for SEM observation of cell morphology.
In vivo study of rabbit femoral bone defect model. The animal experiments were performed following 
an ethical committee approved protocol in accordance with Institutional Animal Ethical Committee (IAEC), 
West Bengal University of Animal and Fishery Sciences (WBUAFS), West Bengal, India (Permit No. Pharma/
IAEC/34 dated 30 June 2014). Sixteen adult New Zealand White rabbits (1.5–2 kg) were randomized into four 
groups (n = 4): control group I (pure BAG) and the test animals, group II (S-BAG), group III (L-BAG) and group 
IV (LS-BAG) with bilateral implantation. All surgeries were performed under general intramuscular anesthesia 
using xylazine hydrochloride (6 mg/kg) (Xylaxin, Indian Immunologicals, India) and ketamine hydrochloride 
(33 mg/kg) (Ketalar, Parke-Davis, India). Scaffolds were press fitted within the created defects in the distal met-
aphyseal region of femur and wounds were sutured in three layers (Fig. 1). Subsequently, animals were admin-
istered with cefotaxime sodium (Mapra India, India) at 20 mg/kg body weight intramuscularly for 5 days twice 
daily at 12 h interval and meloxicam at 0.2 mL (Intas Pharmaceuticals, India) once daily. Animals were finally 
sacrificed after 2 and 4 months of implantation.
Characterization of in vivo samples. Bone healing in the defect was monitored using chronological radi-
ographs taken immediately after implantation and once in a month up to 4 months. Radiographs were scored 
independently by double blinded investigators per methods described by Zhukauskas et al.30 (Table 2). For histo-
logical analysis, the bone specimens from the healed bone defect were collected, washed thoroughly with normal 
saline and was immediately fixed in 10% formalin for 7 days. Subsequently, the bone tissues were decalcified using 
Goodling and Stewart’s fluid containing 15 mL formic acid, 5 mL formalin and 80 mL distilled water, followed by 
fixation with 4% paraformaldehyde. Finally, the samples were embedded in paraffin wax and 4 μ m sections were 
cut from the mount and stained with haematoxyline and eosin finally. Additional scoring system was developed 
from the histological slide using several in vivo biological activities (cellular response) and the response score was 
marked with ‘0’ for absence, ‘1’ for mild, ‘2’ for moderate, ‘3’ for marked and ‘4’ for severe activity.
For another set of samples, fluorochrome, i.e. oxytetracycline dehydrate (Pfizer India, India) was intramus-
cularly injected 3 weeks before sacrifice at two time points, i.e., 2 and 4 months (administered at 25 mg/kg body 
weight). Undecalcified ground sections (20 μ m) were prepared from implanted segments of bone using different 
grades of sand paper and observed under UV light with Leica DM 2000 bright light phase contrast and fluo-
rescence microscope including Leica Qwain software. Golden yellow fluorescing area was observed to identify 
newly formed bone and was also measured in μ m2 and converted to percentage of bone formation. The extracted 
samples were also observed using SEM for bone-implant interfacial characteristics. Samples were first fixed in 
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5% glutaraldehyde in PBS buffer for 48 hours followed by gradual ethanol series drying. Dried samples were gold 
coated before imaging using the same desktop SEM, described earlier.
Micro-computed tomography (μ -CT) images of extracted bone samples with inserted scaffolds (BAG, L-BAG, 
S-BAG and LS-BAG) were taken using XT-H 225 (Nikon Metrology, Belgium) with maximum 110 kV rotating 
target X-ray source (75 μ A test current), spot size 3 μ m, resolution: ~12 μ m and 5-axis manipulator. Images thus 
obtained were qualitatively assessed for bone in-growth into the scaffolds.
Statistical analysis. Radiological and histological images for all groups of animals were analyzed as 
means ± standard deviations and data has been analyzed by SPSS software package (Version 16, SPSS Inc., 
Chicago, USA) employing two-way ANOVA considering group and month as factors.
Results and Discussions
Bioactive glass powder characterization. Fig. 2a–d shows the DTA thermogram of as-prepared powder 
samples (melted at 1450 °C) without and with Li/Sr doping. Glass transition temperatures (Tg) was found to be 
around 750 °C for BAG and 790, 780 and 770 °C respectively for L-BAG, S-BAG and LS-BAG with crystalliza-
tion temperature 862 and 865 °C for BAG and L-BAG respectively. With the addition of dopants, Tg increases 
Figure 1. Surgical placement of the porous scaffolds (with or without doped BAG). 
Animal response Score description
1 Bone just extending into the defect
2 Bone substantially bridging the cortical defect
3 Bone fully bridging the cortex without significant callus
4 Bone fully bridging the cortex with distinct overlying callus
Table 2.  Radiological scoring system (adopted as per Zhukauskas et al.30).
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from the base composition (BAG) with associated enthalpy increase as well. No adsorbed or structural water 
loss noticed throughout the temperature regime. Heat treatment temperature of the porous green specimens 
fabricated later with this powders were selected based on the repeated trials on the porous green specimens with 
suitable strength, unaffected porous network inside and no incipience of glassy or crystalline phase.
XRD pattern (Fig. 3) of respective heat treated specimens for each composition confirms amorphous nature 
with broad diffraction at 2θ ranging between 20–35° indicative of disorder in the structure and glassy nature of 
powders. Addition of dopants had no appreciable influence on the glassy structure of base material except slight 
changes in amorphicity and no appearance of any crystalline peak.
FTIR spectra (Fig. 4) of same powders show presence of hydroxyl (-OH) group around 3445 cm−1, along with 
Si-O-Si stretching frequency around 465 cm−1 and Si-O-Si bending frequency around 1020 cm−1 for all samples31. 
Other band assignments included Si-OH symmetric stretch at 780–980 cm−1 and vibrational mode of asymmetric 
stretch of Si-O-Si between 1100–1000 cm−1. The band assignments are summarized and are given in Table 3.
Bioactive glass scaffolds characterzation. Fig. 5a–d shows the SEM microstructure of the porous 
scaffolds for all compositions. Highly amorphous microstructures were obtained with presence of granular 
appearance throughout of the samples taken at different magnifications. A range of micro- to macro-pores were 
observed without any grains or crystals.
Due to the amorphous nature, green powders were fused at the boundary with presence of micro-pores 
between the fused powders. Mean pore sizes of BAG and L-BAG samples calculated by image processing was 
about 20 μ m, while this was 47 μ m and 8 μ m for S-BAG and LS-BAG respectively. All the samples except LS-BAG 
showed presence of both micro- (10–50 μ m) and macro-pores (>50 μ m). For LS-BAG, it was more of coarsening 
than sintering of particles. For L-BAG, pore size was found to be in the range of 20–230 μ m with 1–2 μ m small 
pores throughout the microstructure. S-BAG on the other hand had pore size in the range of 30–260 μ m with 
bi-modal distribution of pores in the range from 1–2 μ m and 10–20 μ m. Pore size range for LS-BAG was mainly 
in the range of 10–50 μ m with presence of 1–2 μ m of micro-pores. Amorphous content was found to be more 
in case of L-BAG and LS-BAG compared to S-BAG and BAG. Most probably Li had played a solute-drag effect 
Figure 2. DTA profile of as-prepared samples for (a) BAG, (b) L-BAG, (c) S-BAG and (d) LS-BAG.
Figure 3. XRD patters of (a) BAG, (b) L-BAG, (c) S-BAG and (d) LS-BAG samples heat treated at their 
respective tempertaures.
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for coarsening of the base glass particles. That means Li actually facilitated the coarsening so that green powder 
particles move against each other due to appearance of sharp melt at the interface. The effect was more evident in 
case of LS-BAG. Strontium on the other hand, did not have such effect as mentioned. As a consequence porous 
scaffolds made of BAG and S-BAG showed similar percentage of apparent porosity when heat treated as that of % 
naphthalene added while preparing the green compacts. But L-BAG and LS-BAG had much higher percentage of 
open porosity. As a result bulk densities of the samples were found to be higher in case of BAG and S-BAG than 
L-BAG and LS-BAG. The data (average values) are presented in Table 4.
Simulated body fluid (SBF) study. Fig. 6 shows a composite image showing variations of pH, concen-
trations of calcium, bi-carbonate and bi-phosphate in the supernatant with time, in contact with SBF. pH of the 
supernatant of all samples showed slight decreasing tendency with time and upto day 14, which corroborates our 
earlier findings on similar base glass32. For all the samples, Ca ion concentration of the supernatant was increased 
from 7 to 14 days except S-BAG, which showed increment of Ca ions at day 7 and continuous maintenance upto 
day 14. For BAG, L-BAG and LS-BAG this increase of Ca was due to dissolution from sample surface. HPO42− ion 
conc. on the other hand was decreased from pure SBF, most probably due to phosphate deposition on the surface. 
Carbonate in the supernatant, showed a decrement at day 7 and subsequent increment at day 14 which was possi-
bly due to more carbonate deposition on the surface at day 7, more dissolution upto day 14 and eventually becom-
ing saturated with the sample. The concentration of the supernatant analysis upto day 14 revealed bioactivity of 
the samples in terms of more and more -OH and PO43− ion deposition on the sample surface, which is a potential 
nucleation site for Ca after day 14 to form hydroxyapatite or carbonated apatite on its surface; but, S-BAG showed 
better bioactivity as the same deposition was prominent within day 14. The results obtained were compared with 
the MTT assay study shown later
Fig. 7 show the SEM microstructure of the porous scaffold surface after day 14 of SBF study. This shows for-
mation of apatite like crystals on the surface of S-BAG (Fig. 7c) which was not very clear in case of other samples 
surfaces. L-BAG and LS-BAG showed amorphous nature of their respective surfaces (Fig. 7b,d), as kinetics of 
dynamic dissolution and deposition process of Ca2+, HCO3− and HPO42− ions were still in continuation while for 
BAG (Fig. 7a), deposition of apatite like crystals have started.
In vitro cell cyto-toxicity study. From the calculated OD values (550 nm), percent cell (NIH3T3) prolifer-
ation was plotted against the days observed and is given in Fig. 8.
It was found that the initial proliferation of cells after day 3 was better than control due to initial attach-
ment of cells. After 7 days, however, this was found to be better in case of L-BAG than the others. Cell growth 
rate was found to be reduced for all samples than control. All sample surface was considered as non-toxic and 
Figure 4. FTIR spectra of (a) BAG, (b) L-BAG, (c) S-BAG and (d) LS-BAG samples heat treated at their 
respective temperatures.
Wave number (cm−1) Band assignment Wave number (cm−1) Band assignment
465 δ (Si-O-Si) bending 1630 δ (OH)
595 P-O of PO32− group 2853 − OH (water)
784 ν (Si-O-Si) tetrahedral 2923 ν (CH)
1020 ν (Si-O-Si) asymmetric 3445 ν (OH)
Table 3.  Band assignments for the peaks obtained for all samples (cf. Fig. 4).
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biocompatible. Cell morphology by SEM after day 7 was also revealed similar trend (Fig. 9) as L-BAG showed 
better NIH3T3 proliferation than other surfaces. Well-grown filopodia (microspikes) or cytoplasmic projections 
were seen and found to be more pronounced in this case. Filopodia contain actin filaments cross-linked into 
bundles by actin-binding proteins. Micropores present on the top of surface play pivotal role for better anchorage 
of the filopdia.
NIH3T3 mouse embryo fibroblast cell lines are regularly used for MTT assay to assess cyto-toxicity with 
respect to biomaterials’ effects on cell growth metabolism33. These cells have branched cytoplasm surrounding an 
elliptical nucleus and can be recognized by abundant rough endoplasmic reticulum and also synthesizes extracel-
lular matrix (ECM) and collagen. NIH3T3 has also capability to detect substrate rigidity beyond the cell border34. 
From the results of Figs 8 and 9, it can be stated that there was substantial effect of Li alone to promote fibroblasts 
which was found to be least in case of BAG. S-BAG on the other hand, was not contributing extensively towards 
ECM formation and the gross effect of Li and Sr on cell proliferation was found to be least in case of LS-BAG 
(Fig. 8). S-BAG however showed better bioactivity in terms of apatite like crystal formation which will expected 
to contribute towards bone cell colonization in vivo. In this case, fibroblast cell extensions consolidated the pore 
Figure 5. SEM microstructure of the porous scaffolds for all compositions (inset: higher magnified site). 
Sample A.P., % B.D., g/c.c.
BAG 54.4 ± 1.63 1.16 ± 0.02
L-BAG 61.3 ± 1.84 0.97 ± 0.02
S-BAG 56.5 ± 1.7 1.09 ± 0.02
LS-BAG 64.5 ± 1.94 0.84 ± 0.02
Table 4. A.P. and B.D. data of the porous scaffolds.
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site; ECM formed in situ alongwith HCO3−//HPO42− deposition in contact with SBF after 7 days (Fig. 6) may help 
maturation of bone defect site faster in vivo. The combined effect of Li and Sr thus expected to be generate both 
soft and hard tisue in vivo. Most plausible reason behind slower rate of growth of NIH3T3 after 3 days may be the 
presence of other ions (e.g., Ca2+) which are also consistent with findings reported elsewhere stating that changes 
of extracellular calcium concentration can affect balance between proliferation and differentiation in fibroblasts. 
McNeil et al. demonstrated that elevation of extracellular calcium stimulates proliferation-associated signaling 
pathways in rat fibroblasts35.
Bone in-growth evaluation by micro-CT. Serial slices of X rays were carried out throughout Z-axis of 
a particular implanted bone section, images thus obtained were clubbed together and are given in Fig. 10a,b for 
BAG, 11a,b for L-BAG, 12a,b for S-BAG and 13a,b for LS-BAG after 2 and 4 months respectively. Serial images for 
BAG taken after 2 and 4 months showed that the porous scaffold has started degrading as revealed after 4 months 
but maintained its structure after 2 months. From the grey scale quantification it can be shown that BAG samples 
had higher amount of mature bone tissue after 4 months than the 2 months when more soft tissue apposition was 
evident. Stability of the implant thus impaired after 4 months which is anticipated to be continued and simulta-
neously converted to hard cortical tissue. Effect of lithium and strontium can be an interesting parameter which 
can dictate the degree of bone tissue conversion with time.
Serial sectional images of L-BAG after 2 months showed tissue invasion more in the central part of the implant 
than the periphery with a clear interfacial gap with the surrounding tissue. Grey scale values were found to be in 
between of cortical and cancellous tissues after 2 months which indicates that the implant was in the process of 
being resorbed which was continued up to 4 months. But the degree of resorption was higher in case of L-BAG 
than the BAG alone. L-BAG samples after 4 months showed very similar grey scale values with that of the cortical 
part of the bone. However, degradation of the samples was lowered for L-BAG than BAG alone.
S-BAG samples had clearly shown its efficacy expressed towards conversion to more of cortical tissue than 
the cancellous one. Cortical tissue could be seen at the periphery of the inserted samples as seen after 4 months. 
LS-BAG samples after 2 months showed close resemblance of the cancellous tissue on the periphery and cortical 
tissue in the inside of the implanted samples. After 4 months, the same phenomenon continued and the implanted 
Figure 6. Variations of (a) concentration of supernatant (Ca2+, HCO3− and HPO42−), (b) pH of SBF after days 
7 and 14 in contact with the porous scaffolds (BAG, L-BAG, S-BAG and LS-BAG); (c) is the magnified part of 
HPO42− (a).
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samples were almost 60% converted to the surrounding bone. After 2 months, BAG samples only showed some 
interfacial gap which was absent for all doped samples.
3D images using micro CT are given in “Supplementary Information” as Fig. 1a,b for BAG, 2a and b for 
L-BAG, 3a and b for S-BAG and 4a and b for LS-BAG after 2 and 4 months respectively. The extent to which both 
soft and hard tissue apposed to BAG samples when implanted, cannot be assessed quantitatively from radiog-
raphy. Tissue and blood vessels could be seen in the 3D representation of the micro CT. Porous nature both in 
and outside the medullary cavity were noticed in the 3D representation. Different grey scale values in the images 
represent quality of the bone and its degree of maturity. Implants could be seen from the 3D plots. It was found 
that mature bone tissue as well as blood vessels engulfed the implant which indicates good vascularisation. Porous 
nature of the cortical bone was observed in some sections. In a comparison, LS-BAG samples showed highest 
degree of tissue impregnation and vascularity among the four compositions. Strontium doping synergistically 
affected bone tissue apposition than glass without any doping. BAG scaffolds without doping actually had lower 
vascularity potential than the doped ones.
Radiological examination. Fig. 14a–d shows radiographs of defect surgery site and their interpretation is 
presented in Table 5. On the day of surgery, the distal metaphysis of femur showed presence of partial radiodense 
BAG implant (Fig. 14a) in the defect, which became moth-eaten on 1 month. The implant found to reduce in size 
Figure 7. SEM microstructure of the porous scaffold surface after day 14 of SBF study; for (a) BAG, (b) L-BAG, 
(c) S-BAG and (d) LS-BAG.
Figure 8. MTT assay results; calculated OD values for NIH3T3 expressed on the samples of BAG, L-BAG, 
S-BAG and LS-BAG after days 3 and 7. 
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gradually with implantation time and almost disappeared at 4 month with irregularly arranged bony tissue. In 
S-BAG samples (Fig. 14c), the defect radiodensity appeared to be unchanged after 1 month and the defect size 
shrunk at 2 months. At 3 months, only negligible amount of implant was present in the defect along with newly 
formed bony tissue and by the end of 4 months both the implant defects could be barely seen from the radio-
graphs. L-BAG samples (Fig. 14b) also showed similar performance as that S-BAG, except that defect healing and 
new bone formation were enhanced. In LS-BAG samples (Fig. 14d), radiograph showed narrowing of bony defect 
and shrinkage of implant as early as one month post-operatively. Subsequent radiographs showed no traces of 
implant and defect. More importantly the radiodensity in defect area was almost identical to that of healthy bone.
Histological evaluation. Fig. 15 and Table 6 show the histological section images and evaluation report 
of bone-implant interface at 2 and 4 months after observing different cellular events. BAG scaffolds (Fig. 15a) 
showed well formed bony structure containing haversian system, canaliculi and sinusoidal spaces along with 
deposition of R.B.C., fat cells and scanty numbers of osteoblast in peri-medullary areas after 2 months. Strontium 
doped scaffolds (S-BAG: Fig. 15b) at 2 month showed prominent osteoblastic activity characterized by sufficient 
number of haversian canal, canaliculi, lacunae and osteoblastic cells with suitable cytoplasmic ratios. The bony 
matrix is invaded by highly proliferative branches of vessels containing sufficient amount of R.B.C, bony progen-
itor cells and focal calcified points. Similarly, L-BAG scaffolds (Fig. 15c) showed well developed bony structure 
with robust haversian system, osseous canaliculi and bony plates. The LS-BAG samples (Fig. 15d) depicted well 
formed osseous structure containing haversian canal, lamellae and canaliculi which was invaded by numerous 
blood vessels along with prominent osteoblastic and osteoclastic activities in the margin of lesion.
Histological evaluations at 4 months for the doped and pure bioactive glasses are also shown in Fig. 15a–d. 
Compared to 2 months, apparently higher angiogenesis was observed in all doped samples. However, angiogenic 
proliferation was more in LS-BAG and L-BAG samples compared to other samples. All doped samples showed 
highly proliferative stage of osteoblast and osteoclast cells (progenitor cells) along with foci of calcification.
Figure 9. SEM cell morphology on the samples of (a) BAG, (b) L-BAG, (c) S-BAG and (d) LS-BAG after 7 days.
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Fluorochrome labeling study. Fig. 16 shows images of samples after oxytetracycline marking, where 
golden yellow florescence represents new bone and dark sea green indicates matured old bone. After 2 months, 
BAG scaffolds depicted double tone golden yellow fluorescence in a narrow zone in the defect site and the host 
bone looked dark sea green homogenous color. Relatively, better intensity of new bone formation (golden yellow 
fluorescence) was observed in S-BAG and LS-BAG at this time point. L-BAG at this time point also showed more 
new bone formation as compared to pure sample. At 4 months, all the samples depicted more new bone forma-
tion as compared to 2 month. However, distinct new bone formation was exhibited in all doped bioactive glass 
implants. LS-BAG implanted bone showed wide regions of golden yellow fluorescence (new bone formation) 
indicating rapid bone regeneration. S-BAG bone samples showed scattered and multiple regions new bone forma-
tion in defect area demonstrating their effectiveness in bone regeneration. Based on the calculation, percentage 
of bone formation through fluorochrome labeling images at two time point of 2 and 4 months have been done 
and is given in Table 7.
Scanning electron microscopic (SEM) study. Fig. 17 shows microstructural study of bone implant inter-
face using SEM at two time point of 2 months (Fig. 17a–d) and 4 months (Fig. 17e–h). Effect of lithium and 
strontium could be established in SEM images and compared with the micro CT images. In all samples, with 
time, both soft and hard tissue got matured. L-BAG samples had a clear influence on soft tissue interaction with 
the sample (Fig. 17b,f). Collagenous network was prevalent in case of L-BAG while S-BAG samples (Fig. 17c,g) 
Figure 10. Serial slices along the Z-axis in micro-CT. Images are obtained for implanted BAG scaffolds.  
(a) After 2 months; (b) After 4 months.
Figure 11. Serial slices along the Z-axis in micro-CT. Images are obtained for implanted L-BAG scaffolds.  
(a) After 2 months; (b) After 4 months.
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showed more of matured osteoblastic tissues apposed to the surface of the sample. LS-BAG on the other hand 
showed (Fig. 17d,h) both collagenous network and mature bone tissues, which was not only covered the surface 
but also had invaded the porous network structure of the implant. Interestingly, BAG samples after 4 months 
showed matured osteoblastic tissues (Fig. 17e), but there was also sporadic presence of RBCs on the surface of 
samples. Interfacial gap between the implanted samples and the surrounding bone was found more in case of 
BAG than the other samples. Bony networks could be seen for BAG but no collagenous microstructure. Interfacial 
gap was absent in case of L-BAG and LS-BAG after 4 months but like the BAG samples, S-BAG also revealed slight 
interfacial gap after 2 months which however completely absent after 4 months. Granular nature of the porous 
scaffolds revealed before animal experimentation were absent when implanted. There were no loose or unreacted 
glass particles after animal study.
Figure 12. Serial slices along the Z-axis in micro-CT. Images are obtained for implanted S-BAG scaffolds.  
(a) After 2 months; (b) After 4 months.
Figure 13. Serial slices along the Z-axis in micro-CT. Images are obtained for implanted LS-BAG scaffolds. 
(a) After 2 months; (b) After 4 months.
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Earlier in vitro and in vivo studies on porous bioactive glass scaffolds demonstrated their potentiality towards 
bone tissue engineering due to inherent osteoconductive and osteogenic properties36,37. Further improvement 
in biological properties of these scaffolds can be achieved via incorporation of suitable dopants that positively 
affect osteoblast activities thereby enable early new bone formation6. Amalgamation of trace metallic elements 
into tissue engineering constructs offer low cost, longer shelf life with low regulatory burden and low risk as com-
pared to biologics. Due to these added benefits, delivery of trace metallic element as biological agents is getting 
considerable attention in tissue engineering and regenerative medicine applications38–40. To achieve toward this 
goal of improving the performance of bioactive glasses, a simpler method was identified to develop lithium and 
strontium doped glass and to investigate the mechanism of how these next-generation biomaterials can enhance 
both osteogenesis and angiogenesis for faster patient healing times and high surgical success rates.
Figure 14. Radiographs taken at ‘0’ day, 1, 2, 3 and 4 months post-operatively implanted with (a) BAG,  
(b) L-BAG, (c) S-BAG and (d) LS-BAG.
Group 1 month 2 month 3 month 4 month SEM
S-BAG 0.66a 1.00a 1.66b 2.33bc 0.28
LS-BAG 0.66a 0.66a 1.33b 2.33c 0.28
LS-BAG 1.33a 1.66ab 2bc 3c 0.28
BAG 0.33a 0.66b 1bc 1.66c 0.28
Table 5.  Radiological scoring values of different samples at different time intervals. Values are expressed as 
Mean ± SE. Values with different superscript within a row differs significantly (P < 0.001).
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Li+ is new additive ion of interest that brought attention due to its imminent role in osteogenesis. In a very 
recent study, Miguez-Pacheco et al. has shown that substitution of Na by different % of Li in 45S5 bioactive glasses 
cause decrease in Tg and Tm favoring sintering by viscous flow41 which also consolidates our present finding in 
case of L-BAG. However, we have also completed cell viability and proliferation studies to further strengthen its 
potential application. In another study, it has been reported that 75 patients treated with lithium were found to 
exhibit significantly greater bone mass in several areas compared to 75 normal participants42. Similarly, strontium 
(Sr2+), a non-essential element accounts for 0.035% of the calcium content in our skeleton system and has been 
shown to boost bone regeneration when incorporated into synthetic bone grafts43.
Li+ doping in bioactive glasses may inhibit GSK3, a negative regulator of the Wnt signaling pathway44. 
Moreover, it activates β -catenin-mediated T cell factor (TCF)-dependent transcription during bone and car-
tilage fracture healing45. Similarly, Sr2+enhances osteoclast apoptosis, increases pre-osteoblastic cell prolifera-
tion and collagen synthesis and thus decreases bone resorption and preserve bone formation46,47. In our study, 
radiological study revealed gradual replacement of scaffold with new bone after 2 months in all doped samples. 
Histological study revealed highly proliferative stage of osteoblast and osteoclast cells (progenitor cells) along 
with angio-proliferation component of bony tissue in doped samples compared to pure samples. This is presum-
ably due to possible role of Sr and Li addition in bioactive glass. Sr2+ plays a vital role in overall bone turnover 
through early differentiation of osteoblast that helps in early expression of cbfa1 gene, indispensable for osteoblast 
differentiation48. Sr can also stimulate the calcium sensing receptor and other equivalent signaling pathways to 
induce early osteoblast differentiation46. The Wnt signaling pathway is one of the most key signal cascades in bone 
formation and remodeling process49,50. A direct link between BMP production and an activated Wnt signaling 
pathway in osteoblasts has been observed51,52. The activation of β -catenin signaling by Li+ shows its paramount 
role for fracture healing45. Higher osteoblastic activity and lamellar bone formation are prominent in binary Sr-Li 
doped bioactive glass which is due to combining effects of both dopants on bone formation processes of resorp-
tion and mineral aggregation.
Fluorochrome labeling using tetracycline marker is an indicator for the new bone formation, bone mineraliza-
tion and remodeling53. These stains when incorporated will directly bind to areas undergoing calcification at the 
bone/osteoid (unmineralized bone) interface. After administration, tetracycline generally follows ionized calcium 
and deposited to the areas of mineralized tissue54,55. The labeled new bone and old bone emit bright golden-yellow 
and dark-sea green fluorescence respectively when observed under UV light. The method provides practical 
information in assessing the amount of new bone formation and bone healing56. In this study, at 2 months time 
Figure 15. Histological sections taken after 2 and 4 months post-operatively implanted with (a) BAG,  
(b) S-BAG, (c) L-BAG and (d) LS-BAG.
Cellular Response
Time Point (2 month) Time Point (4month)
Group 1 Group 2 Group 3 Group 4 Group 1 Group 2 Group 3 Group 4
Fibro vascular proliferation 1 ± 0.3 1.66 ± 0.3 1.33 ± 0.3 1.66 ± 0.3 1.33 ± 0.3 1.66 ± 0.3 1.33 ± 0.3 1.66 ± 0.3
Mononuclear cell 1 ± 0.23 1 ± 0.23 1 ± 0.23 1.33 ± 0.23 1 ± 0.23 1 ± 0.23 1.33 ± 0.23 1.33 ± 0.23
Osteoclast activity 1 ± 0.23 1.33 ± 0.23 1 ± 0.23 1.33 ± 0.23 1 ± 0.23 1 ± 0.23 1.33 ± 0.23 1.33 ± 0.23
Mucin deposit 1.33 ± 0.16 1 ± 0.16 1 ± 0.16 1.33 ± 0.16 1 ± 0.16 1 ± 0.16 1 ± 0.16 1 ± 0.16
Vascularisation 1 ± 0.26 1.33 ± 0.26 1 ± 0.26 1.66 ± 0.26 1.33 ± 0.26 1.66 ± 0.26 1.33 ± 0.26 2 ± 0.26
Osteoblastic activity 1 ± 0.31 1.66 ± 0.31 1.33 ± 0.31 1 ± 0.31 1.33 ± 0.31 1.66 ± 0.31 1.66 ± 0.31 2.3 ± 0.31
Table 6.  Histological scoring values of different samples at 2 and 4 months. Values are expressed as 
Mean ± SE.
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point, the process of new bone formation was moderate in pure bioactive glass and relatively high in all three 
doped samples. In general, the activity of new bone formation was increased in all samples after 4 months. This 
may be due to the significant effects of single or binary dopants which may in turn help in cellular proliferation 
and osteoblastic activity. Previous studies established that Sr can influence cellular activities via the membrane 
bound calcium sensing receptor, both in osteoblasts and in cells of the osteoclasts lineage15,57,58. Moreover, Sr may 
enhance the ability of MSCs as well as pre-osteoblasts proliferation and differentiation into bone-forming oste-
oblasts59, through Wnt/b-catenin pathway by activating mitogenic signaling60. In a similar study using Sr doped 
HAp-based bioactive glasses implants, the sequential polychrome labeling of bone during in vivo osseointegration 
confirmed homogeneous bone formation around the test implants61.
SEM examination revealed both collagenous network and mature bone tissues in L-BAG while S-BAG sam-
ples showed more of matured osteoblastic tissues apposed to the surface of the sample. Interfacial gap between the 
implanted samples and the surrounding bone was found more in pure BAG than the doped other samples. Bony 
networks could be seen for pure BAG but no collagenous microstructure could be noticed, which is an indirect 
estimation of poorer bone quality in case of BAG than the other samples. Interestingly, sporadic presence of RBCs 
on the surface of samples indicating the healing was still continuing. Sr controls key proteolytic enzymes, matrix 
metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) along with osteoprotegrin (OPG) and 
receptor activator of nuclear factor κ -β ligand (RANKL) that is produced by osteoblast cells and are key signaling 
mechanisms of osteoclast formation and its resorptive activity62,63. The combining effect of Sr enhances overall 
bone turn over by reduced osteoclastic resorption and an enhanced osteoblastic activity.
Micro CT in scaffold research has enabled accurate morphological studies to be carried out, yielding com-
prehensive data sets64,65. It also opened a new paradigm for investigations in tissue engineering66. Micro CT thus 
performed to understand the degree of vascularity as well as the interaction of soft and hard tissue with the mate-
rial when implanted. In the present study, mature bone tissue as well as blood vessels engulfed the implant which 
indicates good vascularisation. In a comparison LS-BAG samples showed highest degree of tissue impregnation 
and vascularity among the four compositions probably due to the synergistic effect of lithium and strontium in 
particular. After 2 months, serial sectional images of L-BAG indicated that tissue invasion was more pronounced 
than in the central part of the implant than the periphery with a clear interfacial gap with the surrounding tissue. 
Grey scale values were found to be in between of cortical and cancellous tissues after 2 months which indicates 
that the implant was in the process of resorption. But the degree of resorption was higher in case of L-BAG than 
the BAG alone. S-BAG samples had clearly shown its efficacy expressed towards conversion to more of cortical tis-
sue than the cancellous one. LS-BAG samples after 2 months showed close resemblance of the cancellous tissue on 
the periphery and cortical tissue in the inside of implanted samples. BAG samples only showed some interfacial 
Figure 16. Fluorochrome labeling study (after oxytetracycline markings) taken after 2 and 4 months post-
operatively implanted with (a) BAG, (b) S-BAG, (c) L-BAG and (d) LS-BAG.
Treatment 2 months 4 months
BAG 32.47 ± 0.439bA 48.29 ± 0.541bB
BAG-Sr 23.663 ± 0.513aA 45.432 ± 0.573aB
BAG-Li 39.459 ± 0.562cA 51.466 ± 0.584cB
BAG-Sr + Li 47.459 ± 0.513dA 54.897 ± 0.588dB
Table 7.  Percentage of bone formation through fluorochrome labeling images at two time point of 2 
and 4 months a, b, c, d means with different superscripts within a column differs significantly among the 
treatment (p < 0.01).  A, B mean with different superscript within a row differs significantly between the 
month of sample within a treatment (p < 0.001).
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gap which was absent for all doped samples. In a similar study, the bone regeneration ability of different bioactive 
glass particles has been observed in rabbit model67,68.
In summary, this study examines the effects of Sr and Li addition in bioactive glass compositions developed 
in the lab, the porous scaffolds made thereof for their physico-chemical, in vitro and in vivo osteogenetic proper-
ties alone and in combination. All bioactive glass both doped and undoped showed in vivo new bone formation 
during 4 months. Based on the microstructural, histological, radiological, micro CT and fluorochrome labe-
ling results, Sr and/or Li doped bioactive glass showed acceleration of early-stage bone formation at the rabbit 
model defect site and Sr + Li doped bioactive glass proved to be more effective than other two compositions. 
Our findings suggest that incorporation of Sr and Li in bioactive glass can effectively enhance early stage in vivo 
osseointegration and bone remodeling properties. The results also suggest that doped bioactive glass might pro-
vide a delivery system for bioactive agents to accelerate bone healing and better anchorage of bone implants in 
orthopedic surgery. However, further detailed studies are needed to elucidate the exact mechanisms of Sr and Li 
dopants on enhanced bone healing for suitable use in future biomedical applications as a more osteoconductive 
bone substitute especially on earlier stages after implantation.
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